Literature DB >> 9467937

Expression of p16 induces transcriptional downregulation of the RB gene.

X Fang1, X Jin, H J Xu, L Liu, H Q Peng, D Hogg, J A Roth, Y Yu, F Xu, R C Bast, G B Mills.   

Abstract

The RB and p16(INK4A) tumor suppressor genes function in the same pathway of cell cycle control. Previous evidence indicates that the p16(INK4A) gene is transcriptionally repressed by the RB gene product, pRB. In this study using human ovarian cancer cell lines, we found that RB protein and mRNA were expressed at higher levels in cell lines lacking p16 than in those with normal p16. Since this suggests a potential role of p16 in regulating the cellular level of pRB, we studied the effect of wild-type p16(INK4A) on expression of the RB gene. Introduction of p16(INK4A), carried by an adenovirus vector, into p16-negative cell lines dramatically decreased expression of RB protein and mRNA. Nuclei run-off assays demonstrated that p16 expression induced transcriptional downregulation of the RB gene. These results indicate that expression of RB is inversely regulated by p16. The findings reveal a new dimension of pRB-p16 interaction and should have implications for p16(INK4A)-mediated gene therapy.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9467937     DOI: 10.1038/sj.onc.1201525

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  13 in total

1.  The kinetic origins of the restriction point in the mammalian cell cycle.

Authors:  B D Aguda; Y Tang
Journal:  Cell Prolif       Date:  1999-10       Impact factor: 6.831

2.  Lysophosphatidic acid activates lipogenic pathways and de novo lipid synthesis in ovarian cancer cells.

Authors:  Abir Mukherjee; Jinhua Wu; Suzanne Barbour; Xianjun Fang
Journal:  J Biol Chem       Date:  2012-06-03       Impact factor: 5.157

3.  Conditional expression of the tumor suppressor p16 in a heterotopic glioblastoma model results in loss of pRB expression.

Authors:  Matthias Simon; Christian Simon; Gertraud Köster; Volkmar H J Hans; Johannes Schramm
Journal:  J Neurooncol       Date:  2002-10       Impact factor: 4.130

4.  Central giant cell lesion of the jaws: study of CCND1 gene amplification and p16INK4a protein levels.

Authors:  Renato Luiz Maia Nogueira; Mário Henrique Girão Faria; Rafael Lima Verde Osterne; Roberta Barroso Cavalcante; Ronaldo Albuquerque Ribeiro; Cassiano Francisco Weege Nonaka; Silvia Helena Barem Rabenhorst
Journal:  J Mol Histol       Date:  2013-03-16       Impact factor: 2.611

5.  Ovarian cancer cells, not normal cells, are damaged by Mirk/Dyrk1B kinase inhibition.

Authors:  Jing Hu; Holly Deng; Eileen A Friedman
Journal:  Int J Cancer       Date:  2012-11-21       Impact factor: 7.396

6.  Potassium channel activation inhibits proliferation of breast cancer cells by activating a senescence program.

Authors:  K Lansu; S Gentile
Journal:  Cell Death Dis       Date:  2013-06-06       Impact factor: 8.469

7.  A novel function for the tumor suppressor p16(INK4a): induction of anoikis via upregulation of the alpha(5)beta(1) fibronectin receptor.

Authors:  T Plath; K Detjen; M Welzel; Z von Marschall; D Murphy; M Schirner; B Wiedenmann; S Rosewicz
Journal:  J Cell Biol       Date:  2000-09-18       Impact factor: 10.539

8.  Independent prognostic significance of cell cycle regulator proteins p16(INK4a) and pRb in advanced-stage ovarian carcinoma including optimally debulked patients: a translational research subprotocol of a randomised study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group.

Authors:  S Kommoss; A du Bois; R Ridder; M J Trunk; D Schmidt; J Pfisterer; F Kommoss
Journal:  Br J Cancer       Date:  2007-01-29       Impact factor: 7.640

9.  Role of p16(INK4A) in Replicative Senescence and DNA Damage-Induced Premature Senescence in p53-Deficient Human Cells.

Authors:  Razmik Mirzayans; Bonnie Andrais; Gavin Hansen; David Murray
Journal:  Biochem Res Int       Date:  2012-08-13

10.  p16INK4a-induced senescence is disabled by melanoma-associated mutations.

Authors:  Sebastian Haferkamp; Therese M Becker; Lyndee L Scurr; Richard F Kefford; Helen Rizos
Journal:  Aging Cell       Date:  2008-10       Impact factor: 9.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.